Number 10

Hope or hype?

Editorial 1 January 2006 0

Decades of experience have taught us to guard against the temptation to trumpet early impressive results as breakthroughs. Yet some of the comments over the promising results from trials testing Herceptin (trastuzumab) in early-stage breast [more]

... [ more ]

Michael Baumann: the dynamo of Dresden

Cover Story 1 January 2006 0

Michael Baumann went into radiation oncology because it has all the biological interest of medical oncology with added technical excitement. He claims the new targeted therapies will only come into their own when combined with [more]

... [ more ]

Lost in translation

Grandround 1 January 2006 0

Cancer drugs often deliver less than they promise. The BDA believes the problem may lie not in the drugs themselves, but in the way they are targeted, tested and used. It organises regular get-togethers where [more]

... [ more ]

What’s coming up in colorectal cancer?

Grandround 1 January 2006 0

A panel of experts is predicting that colorectal cancer patients will soon feel the benefits of the sort of individualised therapies that are beginning to be used in breast cancer. More effort is needed to [more]

... [ more ]

Gynaecological oncology: Hungary has a word for it

Senza categoria 1 January 2006 0

Péter Bösze, professor, gynaecologist, geneticist, chemotherapist, radiotherapist and teacher, helped found the Budapest school of radical surgery. Today he is still encouraging young gynae-oncologists to think radically and practise holistically – and he is helping [more]

... [ more ]

Can science win back public trust?

Spotlight on 1 January 2006 0

Confidence in science is becoming dangerously eroded in the face of a rise in religious fundamentalism and a general scepticism that scientific advances will be used for the good of humanity as a whole. Will [more]

... [ more ]

The rocky road to unity

Spotlight on 1 January 2006 0

As FECS prepares to welcome organ-based societies through the front door, the medical oncologists threaten to leave by the back. Download full article

... [ more ]

Coming out for breast cancer country by country

Spotlight on 1 January 2006 0

Walks to raise awareness of breast cancer are established traditions in many countries. But in many more, breast cancer remains hidden from public and political agendas. Avon’s Walk Around the World helped connect everyone fighting [more]

... [ more ]

Radiofrequency ablation in hepatocellular carcinoma

Impact Factor 1 January 2006 0

A new study supports the use of image-guided radiofrequency ablation as a first-line treatment for well-selected cirrhotic patients with early-stage hepatocellular carcinoma. Download full article

... [ more ]

Relapsed Hodgkin’s lymphoma: new twist to the standard regimen

Impact Factor 1 January 2006 0

Results of a multicentre study show that a sequential high-dose chemotherapy variant of the standard treatment is safe and effective in relapsed Hodgkin’s patients. Download full article

... [ more ]

NEWSROUND

Senza categoria 1 January 2006 0

Selected press reports compiled by the ESO Cancer Media Centre Download full article

... [ more ]

Two sides to every study

Focus 1 January 2006 0

If research is worth funding at all, isn’t it worth paying a little extra to make the results – positive or negative – available as freely and speedily as possible? Download full article

... [ more ]

The drowned and the saved

Senza categoria 1 January 2006 0

In recounting their personal stories, cancer patients are not only sharing their experiences and feelings – they are providing practical support to others and are gradually influencing the way cancer is perceived and treated. Download [more]

... [ more ]

How the hostage-taking of Twist hit the mass media

Senza categoria 1 November 2005 0

Ioanna Soufleri writes for the Greek daily newspaper To Vima. In a series of articles that jointly won her the 2005 ACE (Awarding Excellence in Cancer) Reporter’s Award, she has shown that progress in cancer [more]

... [ more ]

End this secrecy over clinical trials

Editorial 1 January 2005 0

Ninety-six of every 100 adult cancer patients do not enrol in a clinical trial. One reason is that many trials are shrouded in a veil of secrecy, and patients find it hard to locate one [more]

... [ more ]